156 related articles for article (PubMed ID: 36115970)
1. Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP.
Dong Q; Ou W; Wang M; Jiang T; Weng Y; Zhou X; Tang X
BMC Cancer; 2022 Sep; 22(1):988. PubMed ID: 36115970
[TBL] [Abstract][Full Text] [Related]
2. Role of HDL cholesterol in anthracycline-induced subclinical cardiotoxicity: a prospective observational study in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Ou W; Jiang T; Zhang N; Lu K; Weng Y; Zhou X; Wang D; Dong Q; Tang X
BMJ Open; 2024 Feb; 14(2):e074541. PubMed ID: 38341200
[TBL] [Abstract][Full Text] [Related]
3. Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients.
Zhou X; Weng Y; Jiang T; Ou W; Zhang N; Dong Q; Tang X
BMC Cancer; 2023 Oct; 23(1):976. PubMed ID: 37833648
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Elderly Patients with Diffuse Large B-cell Lymphoma and the Risk Factors Affecting Cardiotoxicity of Anthracycline.
Zhang L; Jing H; Wang L; Tang S; Wang J
Altern Ther Health Med; 2023 Jul; 29(5):358-363. PubMed ID: 37171952
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Global Longitudinal Strain and NT-proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy.
Muckiene G; Vaitiekus D; Zaliaduonyte D; Zabiela V; Verseckaite-Costa R; Vaiciuliene D; Juozaityte E; Jurkevicius R
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241185
[No Abstract] [Full Text] [Related]
6. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy.
Song FY; Shi J; Guo Y; Zhang CJ; Xu YC; Zhang QL; Shu XH; Cheng LL
Int J Cardiovasc Imaging; 2017 Jun; 33(6):857-868. PubMed ID: 28255826
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial.
Xue K; Gu JJ; Zhang Q; Liu X; Wang J; Li XQ; Luo J; Hernandez-Ilizaliturri FJ; Fernandez SF; Czuczman MS; Cao J; Hong X; Guo Y
Oncotarget; 2016 May; 7(22):32519-31. PubMed ID: 27081036
[TBL] [Abstract][Full Text] [Related]
8. Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
Baech J; Hansen SM; Lund PE; Soegaard P; Brown PN; Haaber J; Jørgensen J; Starklint J; Josefsson P; Poulsen CB; Juul MB; Torp-Pedersen C; El-Galaly TC
Br J Haematol; 2018 Dec; 183(5):717-726. PubMed ID: 30406945
[TBL] [Abstract][Full Text] [Related]
9. Speckle tracking echocardiography in the early detection and prediction of anthracycline cardiotoxicity in diffuse large B-cell lymphoma treated with (R)-CHOP regimen.
Wang B; Yu Y; Zhang Y; Hao X; Zhao H; Yang S; Sun Q; Wang Y
Echocardiography; 2020 Mar; 37(3):421-428. PubMed ID: 32112477
[TBL] [Abstract][Full Text] [Related]
10. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.
Santoro C; Arpino G; Esposito R; Lembo M; Paciolla I; Cardalesi C; de Simone G; Trimarco B; De Placido S; Galderisi M
Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):930-936. PubMed ID: 28379383
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-proBNP and cardiovascular score for risk stratification.
Ferraro MP; Gimeno-Vazquez E; Subirana I; Gómez M; Díaz J; Sánchez-González B; García-Pallarols F; Martínez L; Ble M; Molina L; Belarte LC; Abella E; Elosua R; Comín-Colet J; Salar A
Eur J Haematol; 2019 Jun; 102(6):509-515. PubMed ID: 30972815
[TBL] [Abstract][Full Text] [Related]
12. The early variation of left ventricular twisting function in patients with lymphoma received anthracycline therapy assessed by three-dimensional speckle tracking echocardiography.
Song F; Kang Y; Zhang C; Xu Y; Shi J; Guo Y; Zhang Q; Shu X; Cheng L
Cardiol J; 2017; 24(5):484-494. PubMed ID: 28353310
[TBL] [Abstract][Full Text] [Related]
13. Early anthracycline-induced cardiotoxicity monitored by echocardiographic Doppler parameters combined with serum hs-cTnT.
Zhang CJ; Pei XL; Song FY; Guo Y; Zhang QL; Shu XH; Hsi DH; Cheng LL
Echocardiography; 2017 Nov; 34(11):1593-1600. PubMed ID: 28942608
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular dysfunction in patients with diffuse large B-cell lymphoma undergoing anthracycline-based chemotherapy: a 2D strain and 3D echocardiography study.
Wang B; Yu Y; Zhang Y; Hao X; Yang S; Zhao H; Sun Q; Wang Y
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1311-1319. PubMed ID: 33392873
[TBL] [Abstract][Full Text] [Related]
16. [Early detection of the cardiotoxicity induced by chemotherapy drug through two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T].
Wang W; Kang Y; Shu XH; Shen XD; He B
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):835-840. PubMed ID: 29151290
[No Abstract] [Full Text] [Related]
17. R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.
Sancho JM; Fernández-Alvarez R; Gual-Capllonch F; González-García E; Grande C; Gutiérrez N; Peñarrubia MJ; Batlle-López A; González-Barca E; Guinea JM; Gimeno E; Peñalver FJ; Fuertes M; Bastos M; Hernández-Rivas JÁ; Moraleda JM; García O; Sorigué M; Martin A
Cancer Med; 2021 Feb; 10(4):1314-1326. PubMed ID: 33492774
[TBL] [Abstract][Full Text] [Related]
18. Anthracycline induced inconsistent left ventricular segmental systolic function variation in patients with lymphoma detected by three-dimensional speckle tracking imaging.
Xu Y; Shi J; Zhao R; Zhang C; He Y; Lin J; Zhang Q; Shu X; Cheng L
Int J Cardiovasc Imaging; 2019 May; 35(5):771-779. PubMed ID: 30684081
[TBL] [Abstract][Full Text] [Related]
19. [Late cardiotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma].
Dorokhina EI; Magomedova AU; Shevelev AA; Kulikov SM; Gitis MK; Vedernikov AV; Vorobyev AI; Kravchenko SK
Ter Arkh; 2015; 87(7):51-57. PubMed ID: 26390725
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the ONCO-ECHO study.
Mizia-Stec K; Elżbieciak M; Wybraniec MT; Różewicz M; Bodys A; Braksator W; Gąsior Z; Gościniak P; Hryniewiecki T; Kasprzak J; Wojtarowicz A; Zdziarska B; Płońska-Gościniak E
Med Oncol; 2017 Dec; 35(1):14. PubMed ID: 29274027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]